CPHI Milan 2
CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
Volume 16 Issue 3

Combating Counterfeit Drugs: A Multifaceted Approach

Counterfeiting and diversion are global issues that impact virtually every industry, with no organisation immune to the potential damage. Across markets, counterfeit...
Continue Reading →
Volume 16 Issue 3

Studies Support Changing Perspectives Of Glass Vial Performance Characteristics

The global market for glass pharmaceutical containers is projected to exceed $10.5 billion within the next three years, solidifying glass as arguably the most widely...
Continue Reading →
Volume 16 Issue 3

Unlocking the Secrets: Long-term Storage Effects on Pharmaceutical Proteins in Glass and Polymer Prefilled Syringes

In the last few decades, the pharmaceutical industry has experienced rapid growth in parenteral products, leading to easier availability of life-saving drugs in the ...
Continue Reading →
Volume 16 Issue 3

The Global Crisis of Counterfeit Pharmaceuticals: A Call to Action

MM Packaging gathers experts in their field to lay the foundations for the conversation about counterfeit pharmaceuticals; looking into the realities, impact, and po...
Continue Reading →
Volume 16 Issue 3

The Pivotal Role of Patient Advocacy Organisations in Driving Rare Disease Therapeutic Development

Throughout the rare disease clinical development pathway, patient advocacy organisations (PAOs) can and do play crucial roles that exceed supportive functions like r...
Continue Reading →
Volume 16 Issue 3

Listening to the Patient Voice to Improve Eye Care

The growing global ophthalmic eyedroppers market is expected to be driven by the increasing prevalence of eye disease and disorders such as Glaucoma, Dry Eye Disease...
Continue Reading →
Volume 16 Issue 3

How Efficient Logistics Can Change the Lives of Rare Disease Patients

Dr. Danial Arkwell, Head of Global Key Accounts, Pharma at Envirotainer highlights the vital role of efficient logistics in mitigating risk and finding the right sol...
Continue Reading →
Volume 16 Issue 1

Revolutionising Pharmaceutical Logistics: The Path to Sustainable Cooling Solutions

The healthcare industry is at a pivotal moment in its journey toward sustainability, as the demand for efficient cold chain management in transporting and storing me...
Continue Reading →
Volume 16 Issue 3

The Primary Logistics Needs of Life Science Companies

The low volume life science market has significant complexities when it comes to logistics. Shippers must have an educated understanding of Good Distribution Practic...
Continue Reading →
Volume 16 Issue 3

In Silico Modelling for Orally Inhaled and Nasal Drug Product Development

Q&A with Will Ganley, Senior Specialist, Nanopharm. Can you Explain ‘in Silico Modelling’ and What a PBPK Model is? In silico modelling involves using comp...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026